Growth Metrics

Catalyst Pharmaceuticals (CPRX) Cash & Equivalents Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -68.22%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 988.88%
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.00%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 15.64%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 4.77%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 17.50%
7 Evaxion A 62.56 Bn 62.54 Bn - 3.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -4.13%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 67.78%
10 Catalyst Pharmaceuticals 3.82 Bn 3.07 Bn 134.92 Mn 30.17%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 30.17%
Dec 31, 2025 37.02%
Sep 30, 2025 55.97%
Jun 30, 2025 73.76%
Mar 31, 2025 87.06%
Dec 31, 2024 276.03%
Sep 30, 2024 265.65%
Jun 30, 2024 110.13%
Mar 31, 2024 109.39%
Dec 31, 2023 -53.87%
Sep 30, 2023 -52.76%
Jun 30, 2023 -15.23%
Mar 31, 2023 -16.89%
Dec 31, 2022 74.05%
Sep 30, 2022 65.38%
Jun 30, 2022 55.89%
Mar 31, 2022 40.09%
Dec 31, 2021 31.64%
Sep 30, 2021 32.22%
Jun 30, 2021 17.59%
Mar 31, 2021 25.14%
Dec 31, 2020 45.50%
Sep 30, 2020 160.33%
Jun 30, 2020 391.31%
Mar 31, 2020 433.24%
Dec 31, 2019 440.56%
Sep 30, 2019 323.72%
Jun 30, 2019 136.83%
Mar 31, 2019 -2.65%
Dec 31, 2018 -71.20%
Sep 30, 2018 44.85%
Jun 30, 2018 15.19%
Mar 31, 2018 96.38%
Dec 31, 2017 313.85%
Sep 30, 2017 -58.45%
Jun 30, 2017 -54.14%
Mar 31, 2017 -55.10%
Dec 31, 2016 -50.79%
Sep 30, 2016 -46.14%
Jun 30, 2016 -49.71%
Mar 31, 2016 -46.21%
Dec 31, 2015 210.38%
Sep 30, 2015 190.76%
Jun 30, 2015 151.47%
Mar 31, 2015 3,753.13%
Dec 31, 2014 310.51%
Sep 30, 2014 -13.11%
Jun 30, 2014 1,583.76%
Mar 31, 2014 66.00%
Dec 31, 2013 57.17%
Sep 30, 2013 8.26%
Jun 30, 2013 -88.30%
Mar 31, 2013 -86.32%
Dec 31, 2012 -76.61%
Sep 30, 2012 456.55%
Jun 30, 2012 120.63%
Mar 31, 2012 -31.28%
Dec 31, 2011 10.12%
Sep 30, 2011 -65.56%